Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

PaperCitations, authors & open-access status

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 813 citations, 2018 year and closed oa status.

813
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Ofri Mosenzon
Author
John Wilding
Author
The Lancet
Journal
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Bariatric Surgery and Outcomes
Topic
470M+ articles · free account